Reposted by @updates.chemo.org.ukShinyBlackShoe (Calum Polwart) @shinyblackshoe.bsky.social · 26/03/2026There has been a further update to the list today. Several movements to baseline commissioning. 🔔But also noted that #Kadcyla (#Tratsuzumab Emtansine) no longer specifies a LVEF threshold on the blueteq 001
updates.chemo.org.uk @updates.chemo.org.uk · 20/03/2026Nivolumab- Nivolumab plus chemotherapy for neoadjuvant treatment and then continued as adjuvant monotherapy in adults with previously untr... updates.chemo.org.uk/CDF_Forms/NIV2… 🚨 Correction of Nice Approved Indication 000
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Belantamab mafodotin with pomalidomide and...- Belantamab mafodotin with pomalidomide and dexamethasone as 2nd line treatment of relapsed or refractory myeloma in adult patie... updates.chemo.org.uk/CDF_Forms/BELA… 🚨 Spelling of drug name corrected to Belanta... 000
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Belantamab mafodotin in combination with b...- Belantamab mafodotin in combination with bortezomib and dexamethasone as 2nd line treatment of relapsed or refractory myeloma i... updates.chemo.org.uk/CDF_Forms/BELA… 🚨 Spelling of drug name corrected to Belanta... 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Pomalidomide- Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib updates.chemo.org.uk/CDF_Forms/POM1… 🚨 Treatment criterion (#6) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026NA- NA updates.chemo.org.uk/CDF_Forms/NIV9… 🚨 Treatment criterion (#8) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Bevacizumab with FIRST LINE fluoropyrimidi...- For metastatic or locally advanced and inoperable colorectal cancer updates.chemo.org.uk/CDF_Forms/BEV1… 🚨 Treatment criterion (#4) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Abiraterone In combination with androgen d...- For the treatment of newly diagnosed high risk metastatic hormone-sensitive prostate cancer updates.chemo.org.uk/CDF_Forms/ABI4… 🚨 Treatment criterion (#6) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Nivolumab- Nivolumab plus chemotherapy for neoadjuvant treatment and then continued as adjuvant monotherapy in adults with previously untr... updates.chemo.org.uk/CDF_Forms/NIV2… 🚨 Date moving into routine commissioning upd... 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Lorlatinib monotherapy- Lorlatinib monotherapy for anaplastic lymphoma kinase-positive advanced non- small cell lung cancer previously untreated with a... updates.chemo.org.uk/CDF_Forms/LOR2… 🚨 Moved into routine commissioning - section... 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Durvalumab- Durvalumab monotherapy for patients with limited- stage small cell lung cancer whose disease has not progressed following plati... updates.chemo.org.uk/CDF_Forms/DUR7… 🚨 Moved into routine commissioning - section... 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Avelumab in combination with axitinib- For use in treatment-naïve patients with advanced, favourable risk, renal cell carcinoma updates.chemo.org.uk/CDF_Forms/AVE3… 🚨 Moved into routine commissioning - section... 100
updates.chemo.org.uk @updates.chemo.org.uk · 12/02/2026Durvalumab with gemcitabine and cisplatin- For neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancer updates.chemo.org.uk/CDF_Forms/DUR8… 🚨 Recommended for routine commissioning, rec... 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Tivozanib- The treatment of advanced renal cell carcinoma where all the following criteria are met: updates.chemo.org.uk/CDF_Forms/TIV1… 🚨 Treatment criteria (#5, 9 and 10) updated 000
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Fedratinib- For the treatment of patients with myelofibrosis previously treated with ruxolitinib updates.chemo.org.uk/CDF_Forms/FED1… 🚨 Treatment criteria (#5, 9, 10 and 11) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Enzalutamide- Enzalutamide for the treatment of patients with hormone-relapsed (castrate- resistant) metastatic prostate cancer with disease ... updates.chemo.org.uk/CDF_Forms/ENZ5… 🚨 Treatment criteria (#6, 9 and 10) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Enzalutamide- Enzalutamide for the treatment of patients with hormone-relapsed (castrate- resistant) metastatic prostate cancer before chemot... updates.chemo.org.uk/CDF_Forms/ENZ4… 🚨 Treatment criteria (#5, 8 and 9) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Eribulin- Eribulin for treating locally advanced or metastatic breast cancer after 2 or more lines of systemic anti-cancer treatment updates.chemo.org.uk/CDF_Forms/ERIB… 🚨 Title and treatment criteria (#3 and 4) up... 110
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Entrectinib- Entrectinib for ROS1-positive recurrent locally advanced or metastatic non-small- cell lung cancer previously untreated with a ... updates.chemo.org.uk/CDF_Forms/ENT2… 🚨 Treatment criteria (#3, 4, 5, 6, 7, 8 and ... 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Crizotinib- 1st or subsequent line systemic therapy for ROS1-positive inoperable locally advanced/metastatic non squamous non- small cell l... updates.chemo.org.uk/CDF_Forms/CRI3… 🚨 Treatment criteria (#4 and 10) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Abiraterone- For the treatment of patients with hormone-relapsed (castrate-resistant) metastatic prostate cancer with disease progression du... updates.chemo.org.uk/CDF_Forms/ABI2… 🚨 Treatment criteria (#5, 9 and 10) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Abiraterone- Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated updates.chemo.org.uk/CDF_Forms/ABI1… 🚨 Treatment criteria (#6, 10 and 11) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026NA- NA updates.chemo.org.uk/CDF_Forms/ISA2… 🚨 Moved into routine commissioning - section... 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Bevacizumab with FIRST LINE fluoropyrimidi...- For metastatic or locally advanced and inoperable colorectal cancer updates.chemo.org.uk/CDF_Forms/BEV1… 🚨 Recommended for routine commissioning 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026NA- NA updates.chemo.org.uk/CDF_Forms/TUC1… 🚨 Treatment criterion (#8, 10 and 15) updated 000
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Selinexor in combination with bortezomib a...- For the treatment of multiple myeloma transplant ineligible patients who have had only 1 prior line of systemic therapy updates.chemo.org.uk/CDF_Forms/SELI… 🚨 Treatment criterion (#5 and 13) updated; T... 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Olaparib in combination with hormone therapy- As adjuvant treatment of high-risk HORMONE RECEPOR POSITIVE HER 2 NEGATIVE early breast cancer treated with neoadjuvant or adju... updates.chemo.org.uk/CDF_Forms/OLAP… 🚨 Treatment criterion (#7 and 10) updated; T... 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026NA- NA updates.chemo.org.uk/CDF_Forms/NIV9… 🚨 Treatment criterion (#9) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Nivolumab- Nivolumab monotherapy (with or without initial combination treatment with ipilimumab) for treating unresectable advanced malign... updates.chemo.org.uk/CDF_Forms/NIV8… 🚨 Treatment criterion (#9) updated 100
updates.chemo.org.uk @updates.chemo.org.uk · 27/01/2026Glofitamab monotherapy- For the treatment of previously treated adult patients with diffuse large B-cell lymphoma who have received 2 or more lines of ... updates.chemo.org.uk/CDF_Forms/GLO1… 🚨 Treatment criterion (#1, 3, 4 and 7) updat... 100
